Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$38.9B
sum of reported positions
Reported positions
652
Changes vs prior quarter
791
244 new · 197 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 557 measured positions in 8 quarters, the typical new or larger position finished −1.9 pts against the S&P 500 and 44% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
ISHARES TR | 4.53M | $3.4B | 8.8% |
| 10.9M | $1.08B | 2.8% | |
| 1.49M | $838M | 2.2% | |
| 4.66M | $730M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $35.4B | $38.9B |
| Positions | 605 | 652 |
| Biggest line | — | ISHARES TR 9% |
| 3.17M |
| $538M |
| 1.4% |
| 1.34M | $499M | 1.3% |
| 1.07M | $424M | 1.1% |
| 1.77M | $422M | 1.1% |
| 2.32M | $409M | 1.1% |
| 23.4M | $371M | 1.0% |
| 775K | $356M | 0.9% |
| 895K | $356M | 0.9% |
| 1.05M | $333M | 0.9% |
| 1.25M | $329M | 0.8% |
| 2.48M | $319M | 0.8% |
| 1.17M | $298M | 0.8% |
| 3.04M | $292M | 0.8% |
| 856K | $283M | 0.7% |
| 1.71M | $282M | 0.7% |
| 291K | $281M | 0.7% |
| 6.81M | $269M | 0.7% |
| 1.85M | $261M | 0.7% |
| 2.73M | $251M | 0.6% |
| 984K | $246M | 0.6% |
| 11.3M | $244M | 0.6% |
First Citizens Bancshares Inc (FCNCA)
3,332 shares
Hyatt (H)
35K shares
Ovintiv (OVV)
1.71M → 129K shares (−93%)
Syndax Pharmaceuticals (SNDX)
309K shares
ISHARES BITCOIN TRUST ETF
200K shares
PVH Corp. (PVH)
89K shares
Aib Data Centers (AIB)
3.03M shares
Regency Centers (REG)
79K shares
Lincoln International (LCLN)
265K shares
Solidion Technology (STI)
679K shares
Aura Minerals (AUGO)
100K shares
Magnite (MGNI)
327K shares
Infleqtion (INFQ)
5M → 465K shares (−91%)
Dpc Holdings (DPC)
125K shares
Crescent Energy Company (CRGY)
1.3M → 616K shares (−52%)
SM Energy Company (SM)
545K → 231K shares (−58%)
Marathon Petroleum (MPC)
23K shares
Jfrog (FROG)
64K shares
Denali Therapeutics (DNLI)
1.94M → 219K shares (−89%)
Hmh Holding (HMH)
300K shares
Celanese (CE)
89K → 120K shares (+35%)
Dyne Therapeutics (DYN)
245K shares
Hawkeye 360 (HAWK)
265K shares
Roivant Sciences (ROIV)
148K shares
Nuvectis Pharma (NVCT)
275K shares
